NASDAQ : IRWD
Ironwood Pharmaceuticals, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 3.62 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 598.17M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Ironwood Pharmaceuticals, Inc. (IRWD) reported revenue of 389.32M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 389.32M | 296.15M | 351.41M | 442.74M | 410.60M | 413.75M |
| Cost of Revenue | 88.69M | 95.14M | 111.42M | 104.78M | 44.27M | 70.41M |
| Gross Profit | 300.62M | 201.01M | 239.99M | 337.95M | 366.33M | 343.35M |
| Selling, General & Admin | 64.35M | 82.06M | 143.63M | 142.11M | 115.99M | 111.13M |
| Operating Expenses | 64.35M | 82.06M | 143.63M | 142.11M | 115.99M | 111.13M |
| Operating Income | 236.27M | 118.95M | 96.36M | 195.84M | 250.34M | 232.22M |
| Interest Expense | -32.66M | -32.75M | -33.28M | -21.38M | -7.60M | -31.15M |
| Interest & Investment Income | 5.67M | 4.08M | 4.47M | 18.97M | 9.50M | 726.00K |
| Other Non Operating Income (Expenses) | 8.00K | 251.00K | -231.00K | 182.00K | -1.18M | |
| EBT Excluding Unusual Items | 209.29M | 90.28M | 67.79M | 193.20M | 252.42M | 200.61M |
| Merger & Restructuring Charges | -1.91M | -20.26M | -2.59M | -45.82M | 44.00K | |
| Pretax Income | 207.38M | 70.03M | 65.20M | -948.07M | 252.42M | 200.66M |
| Income Tax Expense | 77.51M | 46.01M | 64.32M | 83.49M | 77.36M | -327.79M |
| Earnings From Continuing Operations | 129.87M | 24.02M | 880.00K | -1.03B | 175.06M | 528.45M |
| Net Income to Company | 129.87M | 24.02M | 880.00K | -1.03B | 175.06M | 528.45M |
| Minority Interest in Earnings | 29.32M | |||||
| Net Income | 129.87M | 24.02M | 880.00K | -1.00B | 175.06M | 528.45M |
| Net Income to Common | 129.87M | 24.02M | 880.00K | -1.00B | 175.06M | 528.45M |
| Shares Outstanding (Basic) | 163.13M | 161.84M | 159.08M | 155.44M | 154.37M | 162.25M |
| Shares Outstanding (Diluted) | 165.83M | 162.98M | 160.08M | 155.44M | 186.31M | 164.42M |
| EPS (Basic) | 0.80 | 0.15 | 0.01 | -6.45 | 1.13 | 3.26 |
| EPS (Diluted) | 0.79 | 0.15 | 0.01 | -6.45 | 0.96 | 3.21 |
| Free Cash Flow | 185.55M | 127.01M | 103.41M | 183.15M | 273.63M | 261.63M |
| Free Cash Flow Per Share | 1.12 | 0.78 | 0.65 | 1.18 | 1.47 | 1.59 |
| Gross Margin | 77.22% | 67.88% | 68.29% | 76.33% | 89.22% | 82.98% |
| Operating Margin | 60.69% | 40.17% | 27.42% | 44.23% | 60.97% | 56.12% |
| Profit Margin | 33.36% | 8.11% | 0.25% | -226.37% | 42.64% | 127.72% |
| Free Cash Flow Margin | 47.66% | 42.89% | 29.43% | 41.37% | 66.64% | 63.23% |
| EBITDA | 238.10M | 120.83M | 98.37M | 197.41M | 251.75M | 233.74M |
| EBITDA Margin | 61.16% | 40.80% | 27.99% | 44.59% | 61.31% | 56.49% |
| D&A For EBITDA | 1.83M | 1.88M | 2.01M | 1.57M | 1.42M | 1.52M |
| EBIT | 236.27M | 118.95M | 96.36M | 195.84M | 250.34M | 232.22M |
| EBIT Margin | 60.69% | 40.17% | 27.42% | 44.23% | 60.97% | 56.12% |
| Effective Tax Rate | 37.38% | 65.70% | 98.65% | 30.65% | ||
| Revenue as Reported | 389.32M | 296.15M | 351.41M | 442.74M | 410.60M | 413.75M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 79.13M | 215.46M | 88.56M | 92.15M | 656.20M | 620.13M |
| Cash & Short-Term Investments | 79.13M | 215.46M | 88.56M | 92.15M | 656.20M | 620.13M |
| Accounts Receivable | 112.73M | 46.74M | 81.89M | 129.12M | 115.46M | 114.04M |
| Receivables | 112.73M | 46.74M | 81.89M | 129.12M | 115.46M | 114.04M |
| Prepaid Expenses | 7.34M | 11.98M | 11.92M | 12.01M | 7.71M | 8.69M |
| Restricted Cash | 1.25M | 1.25M | ||||
| Other Current Assets | 1.11M | |||||
| Total Current Assets | 199.20M | 274.18M | 182.37M | 233.29M | 780.63M | 745.23M |
| Property, Plant & Equipment | 11.36M | 12.75M | 15.52M | 18.17M | 20.31M | 22.93M |
| Other Intangible Assets | 1.63M | 2.04M | 2.86M | 3.68M | ||
| Long-Term Deferred Tax Assets | 69.06M | 103.43M | 144.23M | 212.32M | 283.66M | 333.29M |
| Long-Term Deferred Charges | 2.40M | 2.90M | 3.90M | 2.40M | ||
| Other Long-Term Assets | 1.47M | 1.60M | 2.02M | 1.21M | 15.92M | 25.48M |
| Total Assets | 285.13M | 396.90M | 350.91M | 471.07M | 1.10B | 1.13B |
| Accounts Payable | 911.00K | 2.90M | 2.13M | 7.83M | 483.00K | 935.00K |
| Accrued Expenses | 14.50M | 19.18M | 26.00M | 47.22M | 17.71M | 33.29M |
| Current Portion of Long-Term Debt | 199.68M | 199.56M | 116.86M | |||
| Current Portion of Leases | 3.29M | 3.25M | 3.19M | 3.13M | 3.06M | 3.13M |
| Current Income Taxes Payable | 4.28M | 927.00K | 521.00K | 1.24M | 656.00K | |
| Current Unearned Revenue | 1.25M | 1.11M | 2.03M | 2.62M | ||
| Other Current Liabilities | 8.62M | 15.18M | 4.98M | 14.50M | 3.61M | 7.49M |
| Total Current Liabilities | 32.85M | 242.22M | 38.85M | 276.10M | 25.52M | 161.70M |
| Long-Term Debt | 385.00M | 385.00M | 583.99M | 498.31M | 396.25M | 337.33M |
| Long-Term Leases | 8.58M | 9.87M | 12.30M | 14.54M | 16.60M | 18.48M |
| Long-Term Unearned Revenue | 4.40M | 5.30M | ||||
| Other Long-Term Liabilities | 16.14M | 16.35M | 17.11M | 28.41M | 9.77M | 3.50M |
| Total Liabilities | 446.97M | 658.74M | 652.24M | 817.37M | 448.14M | 521.02M |
| Common Stock | 165.00K | 163.00K | 160.00K | 156.00K | 154.00K | 162.00K |
| Additional Paid-In Capital | 1.42B | 1.41B | 1.40B | 1.36B | 1.35B | 1.54B |
| Retained Earnings | -1.58B | -1.67B | -1.70B | -1.70B | -696.38M | -937.61M |
| Comprehensive Income & Other | -324.00K | -1.06M | 923.00K | -3.03M | ||
| Shareholders' Equity | -161.84M | -261.83M | -301.33M | -346.30M | 652.38M | 605.91M |
| Total Liabilities & Equity | 285.13M | 396.90M | 350.91M | 471.07M | 1.10B | 1.13B |
| Total Debt | 396.87M | 597.80M | 599.48M | 715.54M | 415.92M | 475.80M |
| Net Cash (Debt) | -317.74M | -382.35M | -510.92M | -623.38M | 240.29M | 144.33M |
| Net Cash Per Share | -1.92 | -2.35 | -3.19 | -4.01 | 1.29 | 0.88 |
| Filing Date Shares Outstanding | 165.24M | 163.06M | 161.81M | 156.53M | 154.16M | 159.22M |
| Total Common Shares Outstanding | 165.24M | 163.06M | 160.21M | 156.35M | 154.03M | 162.04M |
| Working Capital | 166.35M | 31.96M | 143.52M | -42.81M | 755.10M | 583.53M |
| Book Value Per Share | -0.98 | -1.61 | -1.88 | -2.21 | 4.24 | 3.74 |
| Tangible Book Value | -163.48M | -263.88M | -304.19M | -349.98M | 652.38M | 605.91M |
| Tangible Book Value Per Share | -0.99 | -1.62 | -1.90 | -2.24 | 4.24 | 3.74 |
| Machinery | 3.76M | 3.89M | 5.42M | 4.23M | 4.13M | |
| Leasehold Improvements | 7.44M | 7.41M | 7.41M | 7.41M | 7.41M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 129.87M | 24.02M | 880.00K | -1.00B | 175.06M | 528.45M |
| Depreciation & Amortization | 1.83M | 1.88M | 2.01M | 1.57M | 1.42M | 1.52M |
| Loss (Gain) From Sale of Assets | 4.00K | 89.00K | 75.00K | 2.00K | 93.00K | |
| Asset Writedown & Restructuring Costs | 1.10B | |||||
| Stock-Based Compensation | 14.32M | 17.25M | 29.85M | 32.01M | 27.05M | 22.28M |
| Other Operating Activities | 63.80M | 44.16M | 71.55M | 45.36M | 67.41M | -308.18M |
| Change in Accounts Receivable | -26.56M | 35.15M | 47.24M | 924.00K | 7.99M | 7.71M |
| Change in Accounts Payable | 875.00K | 6.20M | -20.21M | 12.38M | -8.12M | -2.64M |
| Change in Other Net Operating Assets | 1.41M | -1.70M | -27.85M | -2.02M | 2.94M | 12.66M |
| Operating Cash Flow | 185.56M | 127.04M | 103.55M | 183.43M | 273.76M | 261.89M |
| Capital Expenditures | -1.00K | -34.00K | -142.00K | -273.00K | -136.00K | -265.00K |
| Cash Acquisitions | -1.03B | |||||
| Investing Cash Flow | -1.00K | -34.00K | -142.00K | -1.03B | -136.00K | -265.00K |
| Long-Term Debt Issued | 150.00M | 400.00M | ||||
| Long-Term Debt Repaid | -265.00M | -100.00M | -120.70M | |||
| Net Debt Issued (Repaid) | -200.00M | -115.00M | 300.00M | -120.70M | ||
| Issuance of Common Stock | 425.00K | 216.00K | 11.01M | 6.36M | 9.54M | 19.58M |
| Repurchase of Common Stock | -737.00K | -126.39M | -24.13M | |||
| Other Financing Activities | -2.25M | -29.20M | ||||
| Financing Cash Flow | -199.57M | 216.00K | -106.97M | 277.16M | -237.55M | -4.55M |
| Foreign Exchange Rate Adjustments | 296.00K | -329.00K | -32.00K | -53.00K | ||
| Net Cash Flow | -13.72M | 126.90M | -3.60M | -565.78M | 36.07M | 257.08M |
| Free Cash Flow | 185.55M | 127.01M | 103.41M | 183.15M | 273.63M | 261.63M |
| Free Cash Flow Margin | 47.66% | 42.89% | 29.43% | 41.37% | 66.64% | 63.23% |
| Free Cash Flow Per Share | 1.12 | 0.78 | 0.65 | 1.18 | 1.47 | 1.59 |
| Levered Free Cash Flow | 121.83M | 111.69M | 80.71M | 204.13M | 161.46M | 170.05M |
| Unlevered Free Cash Flow | 142.25M | 132.16M | 101.51M | 217.50M | 166.21M | 189.52M |
| Cash Interest Paid | 30.33M | 30.33M | 32.56M | 13.55M | 5.75M | 7.22M |
| Cash Income Tax Paid | 3.54M | 3.54M | 8.41M | 9.95M | 4.62M | 3.45M |
| Change in Working Capital | -24.27M | 39.65M | -819.00K | 11.28M | 2.82M | 17.73M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 571.73M | 548.23M | 708.93M | 1.79B | 1.90B | 1.91B |
| Enterprise Value | 889.47M | 1.01B | 1.24B | 2.41B | 1.74B | 1.80B |
| Last Close Price | 3.46 | 3.37 | 4.43 | 11.44 | 12.39 | 11.66 |
| PE Ratio | 4.39 | 22.83 | 805.60 | 10.86 | 3.61 | |
| Forward PE | 2.76 | 7.84 | 13.42 | 14.14 | 11.24 | 8.43 |
| PS Ratio | 1.47 | 1.85 | 2.02 | 4.03 | 4.63 | 4.61 |
| PB Ratio | -2.09 | -2.35 | -5.16 | 2.91 | 3.15 | |
| P/TBV Ratio | 2.91 | 3.15 | ||||
| P/FCF Ratio | 3.08 | 4.32 | 6.86 | 9.75 | 6.95 | 7.29 |
| P/OCF Ratio | 3.08 | 4.32 | 6.85 | 9.74 | 6.94 | 7.29 |
| PEG Ratio | 1.04 | 1.04 | 1.41 | 2.25 | 1.21 | |
| EV/Sales Ratio | 2.28 | 3.40 | 3.52 | 5.45 | 4.24 | 4.36 |
| EV/EBITDA Ratio | 3.74 | 8.33 | 12.56 | 12.23 | 6.92 | 7.72 |
| EV/EBIT Ratio | 3.76 | 8.46 | 12.82 | 12.33 | 6.96 | 7.77 |
| EV/FCF Ratio | 4.79 | 7.92 | 11.95 | 13.18 | 6.37 | 6.89 |
| Debt / Equity Ratio | -2.45 | -2.28 | -1.99 | -2.07 | 0.64 | 0.79 |
| Debt / EBITDA Ratio | 1.65 | 4.83 | 5.85 | 3.56 | 1.63 | 2.01 |
| Debt / FCF Ratio | 2.14 | 4.71 | 5.80 | 3.91 | 1.52 | 1.82 |
| Net Debt / Equity Ratio | -1.96 | -1.46 | -1.70 | -1.80 | -0.37 | -0.24 |
| Net Debt / EBITDA Ratio | 1.33 | 3.16 | 5.19 | 3.16 | -0.95 | -0.62 |
| Net Debt / FCF Ratio | 1.71 | 3.01 | 4.94 | 3.40 | -0.88 | -0.55 |
| Asset Turnover | 1.24 | 0.79 | 0.85 | 0.56 | 0.37 | 0.49 |
| Quick Ratio | 5.84 | 1.08 | 4.39 | 0.80 | 30.23 | 4.54 |
| Current Ratio | 6.06 | 1.13 | 4.70 | 0.84 | 30.58 | 4.61 |
| Return on Equity (ROE) | -674.04% | 27.83% | 158.09% | |||
| Return on Assets (ROA) | 47.02% | 19.88% | 14.65% | 15.58% | 14.05% | 17.21% |
| Return on Invested Capital (ROIC) | 65.68% | 17.48% | 0.51% | 64.52% | 39.75% | 75.47% |
| Return on Capital Employed (ROCE) | 93.70% | 76.90% | 30.90% | 100.40% | 23.30% | 24.10% |
| Earnings Yield | 22.80% | 4.38% | 0.12% | -56.11% | 9.21% | 27.69% |
| FCF Yield | 32.45% | 23.17% | 14.59% | 10.25% | 14.40% | 13.71% |
| Buyback Yield / Dilution | -3.27% | -1.81% | -2.99% | 16.57% | -13.32% | -2.34% |